The National Cancer Institute (NCI) is offering this Cancer Moonshot Scholars Diversity Program (CMSDP) grant to support independent R01 research projects aligned with NCI’s scientific mission. This grant is specifically designed to increase the number of Early Stage Investigators (ESIs) who receive R01 awards, with a strong focus on individuals from underrepresented groups. The primary purpose of the CMSDP is to diversify NCI’s investigator pool, which in turn is expected to accelerate scientific advancements in cancer research. Investigators from diverse backgrounds, including all underrepresented groups, are highly encouraged to apply for this crucial funding opportunity to contribute to the future of cancer treatment and prevention.
Opportunity ID: 343329
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-22-050 |
| Funding Opportunity Title: | NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.398 — Cancer Research Manpower |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 01, 2022 |
| Last Updated Date: | Sep 01, 2022 |
| Original Closing Date for Applications: | Feb 06, 2024 |
| Current Closing Date for Applications: | Feb 06, 2024 |
| Archive Date: | Mar 13, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments Special district governments State governments Private institutions of higher education Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The overarching goal of the CMSDP is to increase the number of R01 Early Stage Investigators (ESIs) awardees from underrepresented groups (URGs), while promoting scientific advancements through diversification of NCIs investigator pool. Investigators from diverse backgrounds, including those from underrepresented groups (e.g., see NOT-OD-20-031, Notice of NIHs Interest in Diversity), are eligible to apply. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-050.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 343329 Full Announcement-RFA-CA-22-050 -> RFA-CA-22-050-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276636 | Oct 08, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277844 | Nov 01, 2022 | Feb 06, 2024 | View |
Package 1
Mandatory forms
343329 RR_SF424_5_0-5.0.pdf
343329 PHS398_CoverPageSupplement_5_0-5.0.pdf
343329 RR_OtherProjectInfo_1_4-1.4.pdf
343329 PerformanceSite_4_0-4.0.pdf
343329 RR_KeyPersonExpanded_4_0-4.0.pdf
343329 PHS398_ResearchPlan_4_0-4.0.pdf
343329 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343329 RR_Budget_3_0-3.0.pdf
343329 RR_SubawardBudget30_3_0-3.0.pdf
343329 PHS398_ModularBudget_1_2-1.2.pdf
343329 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343329 RR_SF424_5_0-5.0.pdf
343329 PHS398_CoverPageSupplement_5_0-5.0.pdf
343329 RR_OtherProjectInfo_1_4-1.4.pdf
343329 PerformanceSite_4_0-4.0.pdf
343329 RR_KeyPersonExpanded_4_0-4.0.pdf
343329 PHS398_ResearchPlan_5_0-5.0.pdf
343329 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343329 RR_Budget_3_0-3.0.pdf
343329 RR_SubawardBudget30_3_0-3.0.pdf
343329 PHS398_ModularBudget_1_2-1.2.pdf
343329 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
